Provided by Tiger Fintech (Singapore) Pte. Ltd.

Secondary Listings on HKEX

495.646
-5.609-1.12%
Number of Gainers:7
Number of Losers:10
Number of Flat:2
PE:- -
High:506.515
Open:501.067
Low:492.161
Close:501.256
Loading ...

Yum China Holdings Announces New Equity-Based Compensation Plan for Non-Employee Directors

Reuters
·
Yesterday

Yum China Holdings Inc. Files Next Day Disclosure Return to HKEX, Announces Repurchase of 13,850 Shares at HKD 4,662,409.99

Reuters
·
Yesterday

BRIEF-H World Group Signs Agreement To Debut Intercity Hotel, JI Hotel And Orange Hotel In Laos

Reuters
·
Yesterday

H World Group Signs Agreement to Debut Intercity Hotel, Ji Hotel and Orange Hotel in Laos

THOMSON REUTERS
·
Yesterday

Zai Lab Ltd. Announces New Compensation Plan with Grant of Share Options and Restricted Share Units under 2024 Equity Incentive Plan

Reuters
·
05 Jun

BRIEF-JPMorgan Chase & Co's Long Position In Bilibili Increases To 11.68% On May 30 - HKEX

Reuters
·
05 Jun

BRIEF-Blackrock's Long Position In Bilibili Decreases To 5.56% On May 30 - HKEX

Reuters
·
05 Jun

BRIEF-JPMorgan Chase & Co's Long Position In Yum China Increases To 10.40% On May 30 - HKEX

Reuters
·
05 Jun

JPMorgan Chase & Co's Long Position in Yum China Increases to 10.40% on May 30 From 9.44% - HKEX

THOMSON REUTERS
·
05 Jun

Yum China Holdings Inc. Files Next Day Disclosure Return to HKEX, Announces Repurchase of 565,803 Shares at HKD 4,675,680.12

Reuters
·
05 Jun

JPMorgan Chase & Co's Long Position in Bilibili Inc Increases to 11.68% on May 30 From 10.15% - HKEX

THOMSON REUTERS
·
05 Jun

BUZZ-HUTCHMED hits 2-month high on drug application for kidney cancer treatment

Reuters
·
05 Jun

XPeng Strikes Partnership With Huawei

MT Newswires Live
·
05 Jun

HUTCHMED and Innovent Announce Regulatory Review Acceptance in China for Fruquintinib and Sintilimab Combination in Advanced Renal Cell Carcinoma Treatment

Reuters
·
05 Jun

BRIEF-HUTCHMED (China) Says NDA Acceptance In China For Fruquintinib Combination With Sintilimab

Reuters
·
05 Jun

HUTCHMED (China) Ltd - Nda Acceptance in China for Fruquintinib Combination With Sintilimab

THOMSON REUTERS
·
05 Jun

Zai Lab Ltd. CFO Yajing Chen Reports Disposal of Common Shares

Reuters
·
05 Jun

NIO Inc : Mizuho Cuts Target Price to $3.50 From $4

THOMSON REUTERS
·
04 Jun

Yum China Holdings Inc. Files Next Day Disclosure to HKEX Announcing 496,424 Shares Repurchased at HKD 4,672,750.56

Reuters
·
04 Jun

Market Chatter: Nio Considers Trimming R&D Costs By Up to 25%

MT Newswires
·
04 Jun